Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to produce and release growth hormone. It is primarily used to reduce excess abdominal fat in people with HIV-associated lipodystrophy. By promoting growth hormone release, tesamorelin helps improve body composition without significantly increasing overall body weight. It is administered via subcutaneous injection and is usually prescribed under medical supervision due to potential side effects, such as joint pain, swelling, or changes in glucose metabolism.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to produce and release growth hormone. It is primarily used to reduce excess abdominal fat in people with HIV-associated lipodystrophy. By promoting growth hormone release, tesamorelin helps improve body composition without significantly increasing overall body weight. It is administered via subcutaneous injection and is usually prescribed under medical supervision due to potential side effects, such as joint pain, swelling, or changes in glucose metabolism.